MAP
Moody Aldrich Partners Portfolio holdings
AUM
$517M
1-Year Return
38.15%
This Quarter Return
+2.41%
1 Year Return
+38.15%
3 Year Return
+181.18%
5 Year Return
+335.56%
10 Year Return
–
AUM
$513M
AUM Growth
-$74.9M
(-13%)
Cap. Flow
-$72.8M
Cap. Flow
% of AUM
-14.19%
Top 10 Holdings %
Top 10 Hldgs %
16.18%
Holding
249
New
34
Increased
44
Reduced
101
Closed
55
Top Buys
| 1 |
Magnolia Oil & Gas
MGY
|
$6.81M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.78M |
| 3 |
Cadence Bank
CADE
|
$6.49M |
| 4 |
Tidewater
TDW
|
$6.46M |
| 5 |
Vita Coco
COCO
|
$5.59M |
Top Sells
| 1 |
SharkNinja
SN
|
$10.1M |
| 2 |
Cohen & Steers
CNS
|
$9.41M |
| 3 |
BWX Technologies
BWXT
|
$8.47M |
| 4 |
STAG Industrial
STAG
|
$6.59M |
| 5 |
Permian Resources
PR
|
$6.56M |
Sector Composition
| 1 | Healthcare | 17.37% |
| 2 | Industrials | 16.23% |
| 3 | Financials | 14.84% |
| 4 | Consumer Discretionary | 13.64% |
| 5 | Technology | 13.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Apellis Pharmaceuticals
APLS
$3.55B
| – | – |
-6,431
| Closed | -$378K |
|
202
Biohaven
BHVN
$1.68B
| – | – |
-30,547
| Closed | -$1.67M |
|
203
Biogen
BIIB
$20.6B
| – | – |
-2,901
| Closed | -$626K |
|
204
BioMarin Pharmaceuticals
BMRN
$11.1B
| – | – |
-7,049
| Closed | -$616K |
|
205
Celldex Therapeutics
CLDX
$1.52B
| – | – |
-14,687
| Closed | -$616K |
|
|
206
Cohen & Steers
CNS
$3.7B
| – | – |
-122,345
| Closed | -$9.41M |
|
207
Cencora
COR
$56.7B
| – | – |
-1,056
| Closed | -$257K |
|
208
Walt Disney
DIS
$212B
| – | – |
-1,651
| Closed | -$202K |
|
209
DexCom
DXCM
$31.6B
| – | – |
-2,149
| Closed | -$298K |
|
210
Elevance Health
ELV
$70.6B
| – | – |
-528
| Closed | -$274K |
|
211
Exact Sciences
EXAS
$10.2B
| – | – |
-6,059
| Closed | -$418K |
|
212
Gilead Sciences
GILD
$143B
| – | – |
-5,858
| Closed | -$429K |
|
213
Helen of Troy
HELE
$587M
| – | – |
-51,518
| Closed | -$5.94M |
|
214
Incyte
INCY
$16.9B
| – | – |
-5,433
| Closed | -$310K |
|
215
Iovance Biotherapeutics
IOVA
$901M
| – | – |
-224,831
| Closed | -$3.33M |
|
216
IQVIA
IQV
$31.9B
| – | – |
-1,878
| Closed | -$475K |
|
217
Intuitive Surgical
ISRG
$167B
| – | – |
-700
| Closed | -$279K |
|
218
Illinois Tool Works
ITW
$77.6B
| – | – |
-782
| Closed | -$210K |
|
219
Jazz Pharmaceuticals
JAZZ
$7.86B
| – | – |
-1,755
| Closed | -$211K |
|
220
Kinsale Capital Group
KNSL
$10.6B
| – | – |
-1,573
| Closed | -$825K |
|
221
McDonald's
MCD
$224B
| – | – |
-1,086
| Closed | -$306K |
|
222
McKesson
MCK
$85.5B
| – | – |
-473
| Closed | -$254K |
|
223
Medpace
MEDP
$13.7B
| – | – |
-1,110
| Closed | -$449K |
|
224
Neurocrine Biosciences
NBIX
$14.3B
| – | – |
-4,863
| Closed | -$671K |
|
225
Nextracker
NXT
$10.4B
| – | – |
-86,679
| Closed | -$4.88M |
|